The forecast, shared by the pharmaceutical distributor to investors at a conference, comes despite reports of slowing volume.
The stock was also helped by a report from Lazard Capital Markets with data showing pharmaceutical sales rose in August, up 1.9 percent, more than double what was reported for the entire second quarter, according to reports.
McKesson closed up 3.24 points to 62.98.
Read the WSJ report about McKesson.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
